Overweight Individuals Are at Increased Risk for Thrombotic Thrombocytopenic Purpura

American Journal of Hematology

Volumn 74, Issue 3, 2003, Pages 170-174

  Nicol, Kathleen K ^a   Shelton, Brent J ^a   Knovich, Mary Ann ^a   Owen, John ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Obesity; TTP; Weight

Indexed keywords

ARTICLE; BODY WEIGHT; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; RACE; RISK FACTOR; SEX; SURVIVAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; MALE; OBESITY; ODDS RATIO; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 0242361659     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10418     Document Type: Article

References (22)

1. Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United States-analysis of national mortality data, 1968-1991. Am J Hematol 1995;50:84-90.
2. Furlan M, Robles R, Lamie B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-4234.
3. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594.
4. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584.
5. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-494.
6. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001;276:41059-41063.
7. Plaimauer B, Zimmermann K, Volkel D, et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood 2002;100:3626-3632.
8. Meisenberg BR, Robinson WL, Mosley CA, Duke MS, Rabetoy GM, Kosty MP. Thrombotic thrombocytopenic purpura in human immunodeficiency (HIV) -seropositive males. Am J Hematol 1988;27:212-215.
9. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 1996;87:3245-3254.
10. Lesesne JB, Rothschild N, Erickson B, et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781-789.
11. Dzik WH, Georgi BA, Khettry U, Jenkins RL. Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation-successful treatment with plasma exchange. Transplantation 1987;44:570-572.
12. Page Y, Tardy B, Zeni F, Comtet C, Terrana R, Bertrand JC. Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet 1991;337:774-776.
13. Kierdorf H, Maurin N, Heintz B. Cyclosporine for thrombotic thrombocytopenic purpura. Ann Intern Med 1993;118:987-988.
14. Bobbio-Pallavicini E, Gugliotta L, Centurioni R, et al. Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica 1997;82:429-435.
15. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:1773-1777.
16. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-211.
17. Kuczmarski RJ. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr 1992;55:495S-502S.
18. Gasser T, Ziegler P, Seifert B, Prader A, Molinari L, Largo R. Measures of body mass and of obesity from infancy to adulthood and their appropriate transformation. Ann Hum Biol 1994;21:111-125.
19. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 1989.
20. Cleveland WS. Visualizing data. Summit, NJ: Hobart Press; 1993.
21. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991;325:398-403.
22. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397.